|
US2018228907A1
|
|
Cereblon ligands and bifunctional compounds comprising the same
|
|
CN110612297A
|
|
Estrogen receptor proteolytic modulators and related methods of use
|
|
US2018179183A1
|
|
Compounds and methods for the targeted degradation of rapidly accelerated fibrosarcoma polypeptides
|
|
US2018177750A1
|
|
Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide
|
|
WO2018118598A1
|
|
Compounds and methods for the targeted degradation of fetal liver kinase polypeptides
|
|
AU2017367872A1
|
|
Tau-protein targeting protacs and associated methods of use
|
|
CN110506039A
|
|
Compounds and methods for for androgen receptor targeting degradation
|
|
WO2018053354A1
|
|
Indole derivatives as estrogen receptor degraders
|
|
US2017327469A1
|
|
Compounds and methods for the targeted degradation of androgen receptor
|
|
US2017281784A1
|
|
Protein-protein interaction inducing technology
|
|
EP3337476A1
|
|
Compounds and methods for the targeted degradation of bromodomain-containing proteins
|
|
KR20180029061A
|
|
Alanine regulators of protein degradation and related uses
|
|
KR20180035828A
|
|
MDM2 regulators of protein degradation and related uses
|
|
WO2016197114A1
|
|
Tank-binding kinase-1 protacs and associated methods of use
|
|
CN108136044A
|
|
Based on imido proteolysis conditioning agent and associated method of use
|
|
US2016272639A1
|
|
Compounds and methods for the enhanced degradation of targeted proteins
|
|
KR20170103977A
|
|
Compounds and methods for targeted degradation of androgen receptors
|
|
US2016058872A1
|
|
Imide-based modulators of proteolysis and associated methods of use
|
